Company: MDCXW
Filing Date: 2025-09-11
Form Type: DRS
Source: 0001062993-25-015568
Chunk: 235

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-11
Form: DRS
Chunk 235
---
 the Selling Shareholder may be less than or in excess of customary commissions. Neither we nor the Selling Shareholder can presently estimate the amount of compensation that any agent will receive from any purchasers of the common shares sold by the Selling Shareholder.

<div align='center'>155</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

We know of no existing arrangements between the SellingShareholderor any other shareholder, broker, dealer, underwriter, or agent relating to the sale or distribution of the common shares offered by this prospectus.

We may from time to time file with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part to amend, supplement, or update information contained in this prospectus, including, if and when required under the Securities Act, to disclose certain information relating to a particular sale of common shares offered by this prospectus by the SellingShareholder,including with respect to any compensation paid or payable by the SellingShareholderto any brokers, dealers, underwriters, or agents that participate in the distribution of such shares by the SellingShareholder,and any other related information required to be disclosed under the Securities Act.

We will pay the expenses incident to the registration under the Securities Act of the offer and sale of the common shares covered by this prospectus by the SellingShareholder.

As consideration for its irrevocable commitment to purchase our common shares under the SEPA, we have issued to the Selling Shareholder 105,840 of our common shares as Commitment Shares upon execution of the SEPA. In addition, we have paid the Selling Shareholder a structuring fee of $25,000.

We also have agreed to indemnify the Selling Shareholderand certain otherpersons against certain liabilitiesin connection with theoffering of our common shares offered hereby, including liabilities arising under the Securities Act, or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. The Selling Shareholder has agreed to indemnify us against liabilities under the Securities Act that may arise from certain written information furnished to us by the Selling Shareholder specifically for use in this prospectus or, if such indemnity is unavailable, to contribute certain amounts required to be paid in respect of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons,